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A B S T R A C T
EEMS and its successor Society EEMGS have provided a dynamic and successful platform to stimulate research
and exchanges among the different actors involved in the protection of the environment and of human health
from exposure to genome stressors. It includes basic, translational and applied research projects. This was
possible due to the enthusiasm, creativity and support of scientists convinced of the importance of these issues.
In the future young scientists will take over with new questions, new challenges, new technologies, new
discoveries and new applications. A major challenge is the ethical questions emerging from the impressive
potential of present genetic technologies capable of impacting the evolution of nature and humankind. The
EEMGS, where academics, regulators and industries meet, should play a central role in these aspects, in parti-
cular in support of primary prevention and the establishment of internationally recognized guidelines.
Collaboration with colleagues and other teams are of great importance to establish a stimulating open dialogue
on scientific questions. However the key issues remain to do careful and rigorous research; to use logic and
background knowledge; to define adequate experimental designs; to provide transparency in the protocols; to
check repeatability of the results and to combine several statistical approaches in the quest to get to the truth.
Among the many challenges ahead, re-evaluation of some key fundamental questions is necessary, such as the
interplay between genetics and epigenetics, the existence of specific germ cell mutagens or the identification of
the mechanisms leading to mutagen induced diseases. Translational and applied research will further include the
development of systemic biomonitoring protocols, if possible in a single biological sample, the redaction of
internationally harmonized guidelines but also the organization of platforms between geneticists and physicians
open to all actors in the field. The creation of an independent European center to assess risk from exposure to
mutagens, in particular in the light of the problematic of global warming might be very helpful.
1. Goals of EEMGS
The EEMGS (European Environmental Mutagenesis and Genomics
Society) champions the study of mutagens and substances of related
biological activity in the human environment, particularly where there
is concern for public health, by engaging in and sponsoring research
and the study and dissemination of information relating to the fore-
going. Regional Societies of EEMGS are active in many European
countries. The larger ones are found in Germany, United Kingdom,
France, Italy and The Netherlands. Some of the smaller Societies are
those in the countries of Central Europe. EEMGS had the G for
Genomics added to the original society name (EEMS) in 2017 to
broaden the scope to include new genomics technologies.
EEMGS will have existed for 50 years in 2020 and it has been a
scientific and social network for many distinguished and high-profile
researchers. Its key activity has been the annual conferences arranged
in different cities throughout Europe to balance east-west-north-south.
The map in Fig. 1 demonstrates the geographical broadness achieved,
where member societies have developed outstanding days of science
and friendship in collaboration with pan-European scientific boards and
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Fig. 1. Map of locations for annual meetings of EEMGS.
Box 1
The International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS) is a global organization composed of 13
regional Environmental Mutagenesis and Genomics Societies around the world. To better reflect the interests and foci of the member societies,
in the Fall of 2013 the IAEMGS changed its name from the International Association of Environmental Mutagen Societies. The IAEMGS
sponsors and/or otherwise supports a variety of international conferences, most notably the quadrennial International Conference on
Environmental Mutagens (ICEM). The IAEMGS also supports local EMGS meetings, as well as other relevant meetings such as the International
Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis (ICMAA), and the International Conference on Environmental
Mutagens in Human Populations (ICEMHP), and the International Workshops on Genotoxicity Testing. The IAEMGS also provides support for
Alexander Hollaender genetic toxicology training courses, which are regularly held worldwide. By promoting collaboration and commu-
nication among its member societies, the IAEMGS promotes, supports and fosters training and research in genetic toxicology and environ-
mental mutagenesis. (IAEMGS website).
Members of IAEMGS:
Asociación Latinoamericana de Mutagénesis, Carcinogénesis y Teratogénesis Ambiental (ALAMCTA)
Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)
Chinese Environmental Mutagen Society (CEMS)
European Environmental Mutagenesis and Genomics Society (EEMGS)
Environmental Mutagenesis and Genomics Society (EMGS)
Environmental Mutagen Society of India (EMS India)
Iranian Environmental Mutagen Society (IrEMS)
The Japanese Environmental Mutagen Society (JEMS)
Korean Environmental Mutagen Society (KEMS)
Molecular and Experimental Pathology Society of Australasia (MEPSA)
Pan-African Environmental Mutagen and Genomic Society (PAEMGS)
Philippines Environmental Mutagen Society (PEMS)
Thai Environmental Mutagen Society (TEMS)
If you are a member of a local society then you are also a member of the EEMGS. If you are not a member or there is no local society to
become a member of then you can become an individual member of the EEMGS Registered members of the EEMGS will be given access to the
members' only section of the EEMGS website and forum, where they can view newsletters, see/post Job Vacancies and CVs. Members can also
view information on upcoming meetings and submit registration forms and abstracts for the EEMGS annual meeting. (EEMGS website).
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the board of the EEMGS.
EEMGS organised meetings with programmes of interest to scien-
tists with academic, regulatory and industry backgrounds as well as to
other stakeholders. Presentations have highlighted the newest results in
basic, translational and applied science, many at the highest scientific
level. Sessions have focused on mechanisms (e.g. mitosis, meiosis, DNA
repair, cell death, cancer), testing (including new technologies of, for
example, omics), biomonitoring (e.g. occupational exposures and early-
life exposures), regulation (aiming at updating test requirements) and
application (e.g. presenting the newest classification systems related to
genotoxicants as well as carcinogenic and reproductive toxicants).
Keynote lectures have been given by many internationally renowned
speakers along with oral presentations by participants selected from
submitted abstracts. Each year the Frits Sobels Medal is awarded to an
outstanding scientist and an early career scientist can also be nomi-
nated for the Early Career Award. Special support has been given to
young scientists through travel awards and by the inclusion of sessions
dedicated to short presentations and awards for poster presentations
that provide feed-back to presenters.
These rewards for scientists still in the early stages of their careers
have been welcomed by the students and postdocs and their teams and
are seen as the first steps acknowledging excellence and paving the way
for later rewards.
2. History of EEMS/EEMGS
The late Professor Frits H Sobels took the initiative, inspired by the
US initiative in 1969 as described by David DeMarini [1], which led to
the foundation in 1970 of the European Environmental Mutagen So-
ciety (EEMS) as an organization to promote both fundamental and
applied research in the fields of environmental mutagenesis and genetic
toxicology (Box 1).
The foundation of the Society was the result of discussions between
a small group of geneticists and toxicologists who were seriously con-
cerned about possible long-term adverse biological effects of chemicals
in the human environment. The main goal of the Society was to study
and evaluate potential genetic and carcinogenic hazards to humans
from exposure to the increasing number and variety of chemicals in our
environment.
The society was set up as a friendly society with an executive board
consisting of the President elected as Vice President (President-elect)
for 2 years followed by a presidential period for 2 years and finalising
with a Past President period of 2 years. The Office of the Scottish
Charity Regulator (OSCR) in 2016 gave consent to the proposed change
of name to European Environmental Mutagenesis and Genomics
Society.
In Table 1 all Presidents since the Society’s initiation are listed and
Tables 2 and 3 provide the names of winners of awards given by the
Society.
Several awards are given by EEMS/EEMGS. The Frits Sobels Award
recognizes outstanding contributions to the field of environmental
mutagenesis; it may recognise either a lifetime accomplishment or an
episodically pace-making contribution to the field of environmental
mutagenesis. It is presented during the annual EEMGS meeting. The
prize consists of an inscribed token, free registration as well as coverage
of travel and accommodation to the EEMGS meeting at which the
awardee presents a lecture. During the annual meeting, one or more
Early Career Award(s) are also presented. The awardee also presents a
Table 1
List of presidents in the European Society.
President Period
Fritz H. Sobels – The Netherlands 1970–1973
Per Oftedal – Norway 1973–1975
Bryn Bridges – UK 1975–1977
H. Böehme – DDR 1977–1979
Nicola Loprieno – Italy 1979–1981
Udo H. Ehling – West Germany 1981–1983
Clas Ramel – Sweden 1983–1985
Paul H.M. Lohman – The Netherlands 1985–1987
Andrew E. Czeizel – Hungary 1987–1989
B.E. Matter – Switzerland 1989–1991
Ethel Moustacchi – France 1991–1993
Radim Šrám – Czechoslovakia 1993–1995
James M. Parry – UK 1995–1997
Herman Autrup – Denmark 1997–1999
Ilse-Dora Adler – Germany 1999–2001
Angelo Carere – Italy 2001–2003
Kristof Szyfter – Poland 2003–2005
Micheline Kirsch-Volders – Belgium 2005–2007
Eugenia Dogliotti – Italy 2007–2009
David Kirkland – UK 2009–2011
Günther Speit – Germany 2011–2013
Leon Mullenders – The Netherlands 2013–2015
Lisbeth E. Knudsen – Denmark 2015–2017
Helga Stopper – Germany 2017–2019
George Johnson – UK 2019-
Table 2
List of Scientific prize winners.*
Winners of the EEMS Award Year
Fritz H. Sobels – The Netherlands (Environmental mutagenesis in
retrospect) [2]
1986
PD Lawley – UK (carcinogenesis by alkylating agents) 1987
Udo H Ehling – Germany – Genetic risk assessment 1988
Claes Ramel – Sweden – The nature of spontaneous mutations 1989
Adajapalam T Natarajan – The Netherlands – Genomic instability 1990
Bryn A Bridges – UK – DNA repair 1991
Lars Ehrenberg – Sweden – Human health risk assessment and biological
reactive intermediates: hemoglobin binding [3].
1992
Raymond Devoret – France – DNA repair 1993
Winners of the FH Sobels Award (formerly EEMS Award)
H John Evans – UK – Mutation and mutagenesis in inherited and acquired
human disease [4]
1995
Gregorio Olivieri – Italy – Effects and interaction of low dose irradiation 1997
Friedrich E Würgler – Germany [5] 1998
Ethel Moustacchi – France – Fanconi anaemia 1999
Radim J Sram – Czech Republic – Air pollution and genotoxicity 2000
Helmut Bartsch – Germany Hunting for electrophiles that harm human
DNA [6]
2001
Marja Sorsa – Finland – Occupational expsore to genotoxicants 2002
Jim M Parry – UK – Aneuploidy 2003
Alain Sarasin – France – Xeroderma pigmentosum: from symptoms and
genetics to gene-based skin therapy. [7]
2004
Silvio de Flora – Italy – Mechanisms of cancer chemopreventive agents
[8]
2005
Herman Autrup – Denmark – DNA adducts from traffic generated air
pollution
2006
Alan R Lehmann – UK – DNA repair 2007
Leon H Mullenders – The Netherlands – DNA repair 2008
Ilse-Dora Adler – Germany – Aneuploidy 2009
Ricardo Marcos – Spain – Cytogenetic analysis 2010
Micheline Kirsch-Volders – Belgium – In pursuit of the chromosome:
Micronucleus assay in vitro and for human biomonitoring
2011
Peter Farmer – UK – Assessment of oxidatively damaged DNA 2012
David Phillips – UK – DNA adducts: detection, characterisation, biological
consequences
2013
Hansruedi Glatt – Germany – Adducts and metabolic activities 2014
Eugenia Dogliotti – Italy – The response to DNA damage – repair
pathways
2015
Margareta Törnqvist – Sweden – Human exposure to genotoxic agents:
detection, quantification and risk estimation perspectives
2016
Bernd Epe – Germany – Oxidatively generated base modifications in DNA:
Not only carcinogenic risk factor but also regulatory mark? [9]
2017
Andrew R. Collins – UK – The Comet assay 2018
Barbara Tudec – Poland – Understanding the DNA damage removal
mechanisms
2019
* Titles of presentations are from best available sources including PUB MED
searches around the year of presentation.
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lecture at the EEMGS meeting.
Also a limited number of travel grants are available to assist early
career EEMGS members to attend the annual meetings.
3. EEMS and EEMGS: past strengths and challenges
The EEMS was timely established to promote scientific promotion of
a field in full development due to the fast progresses in the deciphering
of genetics, the availability of specific molecular approaches and the
challenging environmental problems associated with pollution by syn-
thetic chemicals. Growing attention to environmental challenges were
seen in the Seveso accident with major exposures to dioxins and
growing concern in rise in cancer incidences, reproductive failures and
effects on wildlife.
The presence of the three major actors involved in the assessment of
environmental mutagenicity - academics, industries and regulators -
implied open dialogues and established scientific impacts on guidelines
not only in the EU but also in collaboration with societies in other parts
of the world, and promoted OECD and other test guidelines.
The establishment of a scientific platform with open discussions and
friendly competition implied many useful collaborations and network
formation related to urgent issues of e.g. genotoxic effects resulting
from accidental releases and spillage and from more insidious ex-
posures.
In earlier years alternating meetings between East and West
European countries promoted scientific exchanges and collaborations
and many young scientists used these meetings to establish exchange
visits with colleagues in their field.
In many instances the meetings have been held at universities to
reduce the cost of participation and to demonstrate the critical im-
portance to the field of environmental health of fundamental research
and teaching taking place in universities.
There have been a number of EU-supported projects validating
methodologies, such as cytogenetics, DNA adducts and the comet assay.
Results of the interlaboratory trials conducted have been a frequent and
valuable feature of EEMGS conferences, often in special sessions.
Publishing results is critical for outreach and the support by two
important scientific editors/journals: Mutation Research and
Mutagenesis have been instrumental in promoting the scientific dis-
semination of advances in the field of environmental mutagenesis.
Finally, financial support from industrial associations has promoted
dialogue between scientists from academic regulatory and industry
bodies. For example, the European Centre for Ecotoxicology and
Toxicology of Chemicals (ECETOC) has supported specific workshops
devoted to the translational aspects of environmental mutagenesis from
the bench to practical issues, previously in 2015 and now again in 2019.
The EEMGS depends on individual initiatives as no major economic
source supports its infrastructure and it relies on individual interest and
institutional back-up. The local organisation of each meeting is a major
effort that has to draw on local support.
The width of the scientific topics to be presented is relatively broad
and some overlap with other scientific societies that have taken over
the role of EEMGS as e.g. in the Nordic countries where EUROTOX is
the international organisation, with local societies, for environmental
scientists.
4. EEMGS: present and future
The decreasing potential/power of the academic world for funda-
mental research in environmental genetics and availability to con-
tribute to the society is a major issue.
In instances of industry sponsored research, questions of in-
dependence and bias are often raised.
In this context, it is of extreme importance to secure the scientific
relevance of the results and the decisions taken by the regulators by
imposing a detailed description of the conflict of interest among
Table 3
List of Young scientist award winners*.
Young Scientist Award Winners Year
Ulf Rannug SE – Environmental mutagens and Ames test, D Siebert – GDR – Environmental mutagens and yeast 1981
Hannu J Norppa – Finland – Cytogenetics 1983
Jan CM van der Hoeven – The Netherlands – Testing in HGPRT and SCE assays 1985
Ileana Quinto – Italy – Mutagenicity of pesticides 1986
Dennis Hellegren – Sweden – Sister chromatid exchange 1989
Manuel Ruiz-Rubio – Spain – Alkylating agents and Ames test 1990
Harry Vrieling – The Netherlands – DNA repair 1991
Helen Tinwell – UK – Genetic toxicology, Anne Stary – France – recombination 1993
Ari Hirvonen – Finland – Genetic polymorhisms and occupational health exposures 1994
Alberto Izzotti – Italy – DNA adducts 1995
Helga Stopper – Germany – Genotoxicity and hormones 1996
Jordi Surrallés – Spain – Links between chromatin structure, DNA repair and chromosome
fragility
1998
Andreas Hartmann – Germany – The Comet assay 1999
Dominique Renault – France – Kinetics of DNA damage, Thomas E. Schmid – Germany – Sperm aneuplouidy 2000
Dorota Butkiewicz – Poland – Genetic polymorphisms, Daniela Cimini – Italy – Mechanisms of aneuploidy 2001
Andreas Rothfuss – Germany – Oxidative stress 2002
Marcus Cooke UK – DNA damage and repair, Gareth Jenkins – UK – Unfolding large-scale genome maps 2003
Mariarosaria D'Errico – Italy – DNA repair 2004
Tomas Helleday – UK/Sweden – PARP2 as target for cancer therapy 2005
Volker Arlt – UK – DNA damage and DNA adduct detection 2006
Karen Brown – UK – Tamoxiphen and DNA adducts 2007
Cecilia Lundin – Sweden – DNA repair pathways as targets for cancer therapy 2008
Shareen Doak – UK – Genotoxic thresholds, DNA repair, and susceptibility in human populations 2009
Eva Petermann – UK – Pathways of mammalian replication fork restart 2010
Ilse Decordier – Belgium – Micronucleus assay and labeling of centromeres with FISH technique. 2011
George E Johnson – UK – Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. 2014
Vanessa Valdiglesias – Coruna, Spain: Characterisation of harmful effects of potentially toxic agents by using cellular and molecular biomarkers 2015
Sabine Langie, Belgium: Environmental and epigenetic programming of complex diseases 2016
Rhiannon David – UK – DNA damage and disease pathways 2018
Julia Bornhorst – Germany – Establishing new testing strategies for C. elegans 2019
* Titles of presentations are from best available sources including PUB MED searches around the year of presentation.
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researchers in publications and evaluators in the commissions.
Among the many challenges ahead of the EEMGS, let us underline
some of them:
-re-evaluate some key fundamental questions which remained un-
solved: do human germ cell mutagens exist [10], which combination(s)
of environmentally induced genomic changes trigger and/or promote
cancer [11–13], how does the interplay between epigenetics and
genetics modulate cell differentiation, evolution and diseases [14,15]
- create a platform between geneticists and physicians involved in
treatment of diseases with a significant genetic component, such as
cancer, neurodegenerative pathologies, and others.
- develop and implement systemic biomonitoring protocols com-
bining physiological, genetic and omics data, if possible in a single
biological sample, e.g. blood, urine or saliva.
- support studies and strategies with beneficial health consequences
in the problematic of global warming.
- support European colleagues and interdisciplinary research in-
itiatives to develop an independent centre to assess the risk from
exposure to mutagens.
- keep on stimulating young scientists to be creative and passionate in
a research field that runs from fundamental to translational and
applied questions in genetics and health.
In the future, young scientists will take over with new questions,
new technologies, new discoveries and new applications. They will
have to face a challenge that is not new but which takes on increasing
importance: the ethical questions emerging from the impressive po-
tential of present genetic technologies capable to impact the evolution
of nature and mankind.
5. Conclusion: Advice to a young researcher
Collaboration with colleagues and other teams is of great im-
portance to establish a stimulating open dialogue on scientific ques-
tions. The EEMGS, where academics, regulators and industries meet,
plays a central role in these aspects, in particular in understanding of
key mechanisms responsible of genetic and epigenetic stresses on the
genome, in support of primary cancer prevention and in the establish-
ment of internationally recognized guidelines to assess risk from mu-
tagens and carcinogens. However, it is necessary to recommend again
and again the basics: to perform careful and rigorous research, to use
logic and background knowledge, to define adequate experimental
designs, to provide transparency in the protocols, to check repeatability
of the results and to combine several statistical approaches in order to
get closer to the truth.
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